Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
St. Jude gene therapy cures babies with 'bubble boy' disease
Novel combination gene therapy pioneered at St. Jude cures "bubble boy" disease and provides template for treating other genetic disorders. Read about the landmark study.
-
St. Jude Children’s Research Hospital and the World Federation of Hemophilia announce collaboration
Collaboration will improve the understanding of how advanced technologies, such as gene therapy for hemophilia B, can move rapidly to countries with limited resources.
-
Research reveals how the most common ALS mutation dooms cells
Toxic DPRs disrupt cell function in ALS, much like uninvited dinner party guests, and displace binding partners that help maintain normal nucleolus and ribosome assembly.
-
St. Jude Children's Research Hospital selected as a finalist in Fast Company magazine's World Changing Ideas Awards
The recognition was earned for sharing several decades worth of genetic cancer data and a five-year collaboration with World Health Organization.
-
AACR: Genetic study identifies a risk factor for stroke among cancer survivors
This investigation draws on whole genome sequencing and other data gathered longitudinally through the St. Jude Lifetime Cohort (SJLIFE) study.
-
Inherited genetic variation linked to risk of T cell leukemia in children
The study identified a novel variant of the USP7 gene as playing a role in increasing the risk of developing T-ALL. The inherited genetic variant is linked to lower expression of USP7.
